Advocacy News

Statement of Lymphoma Research Foundation on Access to Treatment

Policymakers in Washington, DC, and state capitols are considering measures to address the cost of health care, including prescription drugs, and to address insurance adequacy issues.  As debate on these initiatives intensifies, we urge that policymakers consider the needs of people with lymphoma and lymphoma survivors. 

Why the U.S. Needs Non-Profits Now More Than Ever

By Michael Werner and Christina Kazhe The COVID-19 pandemic has brought the country to a crawl. Lawmakers and consumers alike are rightly worried about the economic security of shuttered bars, restaurants, and retail locations. But many have largely ignored the…

LRF Advocates for Patient Access to Cellular Therapies

On November 2, 2019, the Lymphoma Research Foundation sent a letter to Donald Thompson, Director, Division of Acute Care at the Centers for Medicare and Medicaid Services requesting for MS-DRG reclassification for certain cases involving the use of chimeric antigen receptor T-cell (CAR T-cell) therapies.

Congress to Consider Federal Cancer Research Budget

Every year the National Institutes of Health (NIH) and National Cancer Institute (NCI) are required to prepare for the President and the Congress its best professional judgment on the optimal funding needed to make the most rapid progress in the…

LRF Releases Monograph Addressing Early Career Scientist Crisis

In the face of declining federal and institutional resources, the Lymphoma Research Foundation’s (LRF) commitment to supporting early career lymphoma researchers has become more critical than ever before. To explore this important topic, the Foundation convened a Biden Cancer Community…